ELM XR 25/5/1000MG TAB

ELM XR 25/5/1000MG is a triple-action combination tablet designed for comprehensive diabetes management. Each tablet contains Empagliflozin 25mg, Linagliptin 5mg, and Metformin 1000mg—three proven active ingredients that work synergistically to help control blood sugar levels. Empagliflozin helps your kidneys remove excess glucose through urine, while Linagliptin enhances insulin secretion and reduces glucagon levels. Metformin improves insulin sensitivity and decreases hepatic glucose production. This combination approach addresses multiple pathways in type 2 diabetes management. The extended-release formulation ensures steady medication delivery throughout the day, supporting consistent glycemic control with convenient once-daily dosing. Ideal for patients requiring multi-drug therapy to achieve target blood sugar goals. Always use as directed by your healthcare provider. Store in a cool, dry place away from moisture and direct sunlight.